Trevena, Inc.
General ticker "TRVN" information:
- Sector: Health Care
- Industry: Biotechnology
- Capitalization: $885.3K (TTM average)
Trevena, Inc. does not follow the US Stock Market performance with the rate: -36.1%.
Estimated limits based on current volatility of 0.0%: low 0.01$, high 0.01$
Factors to consider:
- Total employees count: 18 (-48.6%) as of 2023
- Top business risk factors: Strategic risks and growth management, Operational and conduct risks, Regulatory and compliance, Labor/talent shortage/retention, Cybersecurity threats
- Current price 99.7% below estimated low
- Earnings for 9 months up through Q3 are below our estimates
Stock Forecast*
* forecast is subjective and experimental, should not be used for any investment decisions
Long term estimates were made for the period from 2023-12-31 to 2025-12-30
- 2023-12-31 to 2024-12-30 estimated range: [6.23$, 22.27$]
- 2024-12-30 to 2025-12-30 estimated range: [3.55$, 13.70$]
Financial Metrics affecting the TRVN estimates:
- Negative: with PPE of -0.3 at the end of fiscal year the price was high
- Negative: negative Operating income
- Negative: Operating cash flow per share per price, % of -13.63 <= 0.33
- Negative: Shareholder equity ratio, % of -18.86 <= 18.93
- Negative: negative Industry operating cash flow (median)
- Negative: negative Net income
- Negative: negative Industry operating income (median)
- Positive: Industry inventory ratio change (median), % of 0 <= 0
Short-term TRVN quotes
Long-term TRVN plot with estimates
Financial data
| YTD | 2021-12-31 | 2022-12-31 | 2023-12-31 |
|---|---|---|---|
| Operating Revenue | $0.57MM | $0.00MM | $3.12MM |
| Operating Expenses | $52.49MM | $56.38MM | $38.41MM |
| Operating Income | $-51.92MM | $-56.38MM | $-35.29MM |
| Non-Operating Income | $0.34MM | $2.71MM | $-4.68MM |
| Interest Expense | $0.00MM | $1.26MM | $3.64MM |
| R&D Expense | $13.43MM | $18.21MM | $16.33MM |
| Income(Loss) | $-51.59MM | $-53.67MM | $-39.97MM |
| Taxes | $0.00MM | $0.00MM | $0.32MM |
| Profit(Loss)* | $-51.59MM | $-53.67MM | $-40.29MM |
| Stockholders Equity | $64.63MM | $15.60MM | $-7.66MM |
| Inventory | $2.35MM | $0.91MM | $0.00MM |
| Assets | $80.12MM | $48.68MM | $40.60MM |
| Operating Cash Flow | $-50.20MM | $-51.48MM | $-33.03MM |
| Capital expenditure | $0.02MM | $0.03MM | $0.04MM |
| Investing Cash Flow | $-0.02MM | $0.02MM | $-0.04MM |
| Financing Cash Flow | $7.73MM | $23.50MM | $26.31MM |
| Earnings Per Share** | $-7.90 | $-7.59 | $-2.84 |
* Profit(Loss) attributable to entity.
** EPS are Split Adjusted, recent splits may be reflected with a delay.